Chris Koddermann (ITPRI) : Rescheduling Psilocybin Globally
Chris Koddermann of the International Therapeutic Psilocybin Initiative is pushing for the UN to reschedule psilocybin.
Psilocybin is quickly becoming recognized as an effective modality for treating depression, anxiety, and other mental health challenges. Yet, the road to decriminalization and legalization of the medicine in the US and on a global scale is still slow going. Join us today with Chris Koddermann of the International Therapeutic Psilocybin Initiative, or ITPRI, to discuss his push for theUN to reclassifies psilocybin as a less dangerous drug.
We begin with Chris’s introduction to psychedelics. He shares his motivation to work pro bono to get psilocybin rescheduling passed. We discuss the Convention of Psychotropic Substances of 1971 and what decriminalization actually means. We close with a deep dive on this current psilocybin initiative, what it means to regulate psilocybin, psilocybin availability, and how you can get involved in moving change forward.
Chris Koddermann is the co-founder and chair of the Board of Directors for the International Therapeutic Psilocybin Initiative (ITPRI). ITPRI brings together an international coalition of leading psychedelic therapy advocacy and research organizations to promote and secure a rescheduling of psilocybin under the 1971 UN Convention on Psychotropic Substances.
Links
- International Therapeutic Psilocybin Rescheduling Initiative (ITPRI)
- WHO Expert Committee On Drug Dependence
- Commission on Narcotic Drugs
- Beckley Psytech
- Multidisciplinary Association for Psychedelic Studies (MAPS)
- Mind Medicine Australia
- Osmond Foundation
- The Open Foundation
- David Nutt’s Drug Science
Contact
- info@reschedulepsilocybin.org
Timestamps
- :05 - Being ‘out’ in the psychedelic space while working in legislation
- :09 - Why do unpaid work to get psilocybin legislation passed?
- :13 - The Single Convention on Narcotic Drugs (1961) & The Convention of Psychotropic Substances (1971)
- :17 - Current restrictions on psilocybin research
- :19 - Decriminalization explained
- :22 - Rescheduling psychedelics
- :31 – Psilocybin Coalition and ITPRI
- :34 - Lessons learned from the rescheduling of cannabis and next steps in psilocybin legalization
- :38 - How to regulate the productions of psilocybin
Show Notes
Links
- International Therapeutic Psilocybin Rescheduling Initiative (ITPRI)
- WHO Expert Committee On Drug Dependence
- Commission on Narcotic Drugs
- Beckley Psytech
- Multidisciplinary Association for Psychedelic Studies (MAPS)
- Mind Medicine Australia
- Osmond Foundation
- The Open Foundation
- David Nutt’s Drug Science
Contact
- info@reschedulepsilocybin.org
Timestamps
- :05 - Being ‘out’ in the psychedelic space while working in legislation
- :09 - Why do unpaid work to get psilocybin legislation passed?
- :13 - The Single Convention on Narcotic Drugs (1961) & The Convention of Psychotropic Substances (1971)
- :17 - Current restrictions on psilocybin research
- :19 - Decriminalization explained
- :22 - Rescheduling psychedelics
- :31 – Psilocybin Coalition and ITPRI
- :34 - Lessons learned from the rescheduling of cannabis and next steps in psilocybin legalization
- :38 - How to regulate the productions of psilocybin
.svg)
